Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid

Caffeine is a promising drug for the management of neurodegenerative diseases such as Parkinson’s disease (PD), demonstrating neuroprotective properties that have been attributed to its interaction with the basal ganglia adenosine A(2A) receptor (A(2A)R). However, the doses needed to exert these neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Dueñas, Víctor, Azuaje, Jhonny, Morató, Xavier, Cordobilla, Begoña, Domingo, Joan Carles, Sotelo, Eddy, Ciruela, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155394/
https://www.ncbi.nlm.nih.gov/pubmed/28264466
http://dx.doi.org/10.3390/molecules22030366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155394/
https://www.ncbi.nlm.nih.gov/pubmed/28264466
http://dx.doi.org/10.3390/molecules22030366

Ejemplares similares